Evicenter
Skyrizi (risankizumab-rzaa) in Plaque psoriasis
Manufacturer
AbbVie Inc.
Prescribing information
Skyrizi (opens in a new tab)
Questions
47
Last updated

All questions

Specific populations: Skyrizi (risankizumab-rzaa) in plaque psoriasis

2 questions · 1 source

Pediatric use

Is Skyrizi approved for children with plaque psoriasis?

Applies to Pediatric patients 6 years of age and older with moderate-to-severe plaque psoriasis

How well does Skyrizi work in children aged 12 and older with plaque psoriasis?

Applies to Pediatric patients 6 years of age and older with moderate-to-severe plaque psoriasis

Note: Table 11 reports the SKYRIZI arm (N=54) only, as n (%); the label does not give the ustekinumab arm results.